Cambrex is an innovative life sciences company with a refreshingly human approach. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

CAMBREX TO ACQUIRE SNAPDRAGON CHEMISTRY, A LEADER IN CONTINUOUS FLOW API DEVELOPMENT SERVICES

Cambrex | November 22, 2022

news image

Cambrex, a leading global contract development and manufacturing organization providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Snapdragon specializes in active pharmaceutical ingredient batch and continuo...

Read More

CAMBREX CAPS LATEST ADDITION OF CONTINUOUS FLOW MANUFACTURING AT NORTH CAROLINA PLANT

fiercepharma | April 18, 2018

news image

CDMO Cambrex, an early adopter of continuous flow manufacturing, has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina. A growing number of pharma companies have been investing in continuous manufacturing because of the cost and time advantages of producing small-molecule drugs. Unlike traditional batch processing, which takes weeks to complete, continuous manufacturing feeds raw materials for solid-dose products through a nonstop ...

Read More

Pharma Tech

CAMBREX COMPLETES FIRST PHASE OF $30 MILLION CAPACITY EXPANSION PROJECT IN HIGH POINT, NORTH CAROLINA

Cambrex | September 05, 2022

news image

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's curre...

Read More

Business Insights, PHARMA TECH

CAMBREX ANNOUNCES THE ACQUISITION OF SNAPDRAGON CHEMISTRY

Cambrex | January 24, 2023

news image

Cambrex, a renowned global contract development and manufacturing organization (CDMO) offering drug substance, product, and analytical services throughout the drug lifecycle, recently announced the completion of its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a diverse range of emerging and established biopharma customers. Snapdragon Chemistry specializes in the development of active pharmaceutical ingredient (API) batch a...

Read More
news image

Business Insights

CAMBREX TO ACQUIRE SNAPDRAGON CHEMISTRY, A LEADER IN CONTINUOUS FLOW API DEVELOPMENT SERVICES

Cambrex | November 22, 2022

Cambrex, a leading global contract development and manufacturing organization providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. Snapdragon specializes in active pharmaceutical ingredient batch and continuo...

Read More
news image

CAMBREX CAPS LATEST ADDITION OF CONTINUOUS FLOW MANUFACTURING AT NORTH CAROLINA PLANT

fiercepharma | April 18, 2018

CDMO Cambrex, an early adopter of continuous flow manufacturing, has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina. A growing number of pharma companies have been investing in continuous manufacturing because of the cost and time advantages of producing small-molecule drugs. Unlike traditional batch processing, which takes weeks to complete, continuous manufacturing feeds raw materials for solid-dose products through a nonstop ...

Read More
news image

Pharma Tech

CAMBREX COMPLETES FIRST PHASE OF $30 MILLION CAPACITY EXPANSION PROJECT IN HIGH POINT, NORTH CAROLINA

Cambrex | September 05, 2022

Cambrex today announced the completion of the first phase of its $30 million investment in its small molecule active pharmaceutical ingredient manufacturing facility in High Point, North Carolina. The newly constructed space adds analytical and chemical development laboratories totaling 30,000 square feet and provides future workspace for 85 analytical and chemical development scientists. These laboratories will support the development of APIs to be manufactured in the facility's curre...

Read More
news image

Business Insights, PHARMA TECH

CAMBREX ANNOUNCES THE ACQUISITION OF SNAPDRAGON CHEMISTRY

Cambrex | January 24, 2023

Cambrex, a renowned global contract development and manufacturing organization (CDMO) offering drug substance, product, and analytical services throughout the drug lifecycle, recently announced the completion of its acquisition of Snapdragon Chemistry, a US-based provider of chemical process development services to a diverse range of emerging and established biopharma customers. Snapdragon Chemistry specializes in the development of active pharmaceutical ingredient (API) batch a...

Read More